Scarano, N.; Di Palma, F.; Origlia, N.; Musumeci, F.; Schenone, S.; Spinelli, S.; Passalacqua, M.; Zocchi, E.; Sturla, L.; Cichero, E.;
et al. New Insights into the LANCL2-ABA Binding Mode towards the Evaluation of New LANCL Agonists. Pharmaceutics 2023, 15, 2754.
https://doi.org/10.3390/pharmaceutics15122754
AMA Style
Scarano N, Di Palma F, Origlia N, Musumeci F, Schenone S, Spinelli S, Passalacqua M, Zocchi E, Sturla L, Cichero E,
et al. New Insights into the LANCL2-ABA Binding Mode towards the Evaluation of New LANCL Agonists. Pharmaceutics. 2023; 15(12):2754.
https://doi.org/10.3390/pharmaceutics15122754
Chicago/Turabian Style
Scarano, Naomi, Francesco Di Palma, Nicola Origlia, Francesca Musumeci, Silvia Schenone, Sonia Spinelli, Mario Passalacqua, Elena Zocchi, Laura Sturla, Elena Cichero,
and et al. 2023. "New Insights into the LANCL2-ABA Binding Mode towards the Evaluation of New LANCL Agonists" Pharmaceutics 15, no. 12: 2754.
https://doi.org/10.3390/pharmaceutics15122754
APA Style
Scarano, N., Di Palma, F., Origlia, N., Musumeci, F., Schenone, S., Spinelli, S., Passalacqua, M., Zocchi, E., Sturla, L., Cichero, E., & Cavalli, A.
(2023). New Insights into the LANCL2-ABA Binding Mode towards the Evaluation of New LANCL Agonists. Pharmaceutics, 15(12), 2754.
https://doi.org/10.3390/pharmaceutics15122754
